Speech Device Granted Medical Device License: A Milestone in Supporting Individuals with Stuttering
In an innovative and noteworthy development, Takalam stuttering device designed for stuttering has been granted a medical device license by the Jordan Food and Drug Administration. This achievement marks a significant milestone in the realm of supporting individuals facing stuttering challenges, affirming the device’s effectiveness in providing support and care to stutterers in Jordan and the broader Arab region.
Examination and Accreditation:
The device received its medical device license after undergoing extensive testing on numerous cases in Jordan. These tests were conducted in collaboration with a team of experts in speech and language from Amman Private University. The device’s performance was reviewed in various scenarios and under different conditions.
Benefits of the Device:
Several benefits of using the speech device for medical purposes have been identified, including:
- Improvement in Speech and Language: The device stimulates the development of speech and language skills for its users.
- Boosting Self-Confidence: It contributes to increased self-confidence among individuals dealing with stuttering.
- Facilitating Communication: The device provides an effective means of communication, enhancing social interaction.
Impact on Society:
This certification has a positive impact on the Takalam company and the community. The device can now be officially considered part of healthcare and medical support essentials. It can be utilized in various healthcare and educational settings to maximize benefits for individuals dealing with stuttering.
With this innovative step, the Takalam device proves to be an effective tool in enhancing the quality of life for individuals facing speech difficulties. This achievement opens up new horizons for technological innovations in supporting individuals with speech challenges.